These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular imaging with targeted contrast ultrasound. Piedra M; Allroggen A; Lindner JR Cerebrovasc Dis; 2009; 27 Suppl 2(Suppl 2):66-74. PubMed ID: 19372662 [TBL] [Abstract][Full Text] [Related]
5. Assessment of inflammation with contrast ultrasound. Lindner JR Prog Cardiovasc Dis; 2001; 44(2):111-20. PubMed ID: 11568823 [TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular imaging with targeted contrast ultrasound. Behm CZ; Lindner JR Ultrasound Q; 2006 Mar; 22(1):67-72. PubMed ID: 16641795 [TBL] [Abstract][Full Text] [Related]
7. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design. Kang ST; Yeh CK Chang Gung Med J; 2012; 35(2):125-39. PubMed ID: 22537927 [TBL] [Abstract][Full Text] [Related]
8. Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality. Price RJ; Kaul S J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):171-80. PubMed ID: 12232566 [TBL] [Abstract][Full Text] [Related]
9. Targeted microbubbles in the experimental and clinical setting. Alzaraa A; Gravante G; Chung WY; Al-Leswas D; Bruno M; Dennison AR; Lloyd DM Am J Surg; 2012 Sep; 204(3):355-66. PubMed ID: 22920405 [TBL] [Abstract][Full Text] [Related]
10. Microbubbles and ultrasound: from diagnosis to therapy. Dijkmans PA; Juffermans LJ; Musters RJ; van Wamel A; ten Cate FJ; van Gilst W; Visser CA; de Jong N; Kamp O Eur J Echocardiogr; 2004 Aug; 5(4):245-56. PubMed ID: 15219539 [TBL] [Abstract][Full Text] [Related]
14. Targeted therapeutic applications of acoustically active microspheres in the microcirculation. Chappell JC; Price RJ Microcirculation; 2006 Jan; 13(1):57-70. PubMed ID: 16393947 [TBL] [Abstract][Full Text] [Related]
15. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118 [TBL] [Abstract][Full Text] [Related]
16. Molecular imaging of disease with targeted contrast ultrasound imaging. Inaba Y; Lindner JR Transl Res; 2012 Mar; 159(3):140-8. PubMed ID: 22340763 [TBL] [Abstract][Full Text] [Related]
17. New development and application of ultrasound targeted microbubble destruction in gene therapy and drug delivery. Chen ZY; Yang F; Lin Y; Zhang JS; Qiu RX; Jiang L; Zhou XX; Yu JX Curr Gene Ther; 2013 Aug; 13(4):250-74. PubMed ID: 23721204 [TBL] [Abstract][Full Text] [Related]
18. High-speed optical observations of contrast agent destruction. Bouakaz A; Versluis M; de Jong N Ultrasound Med Biol; 2005 Mar; 31(3):391-9. PubMed ID: 15749563 [TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Lindner JR Nat Rev Cardiol; 2009 Jul; 6(7):475-81. PubMed ID: 19506587 [TBL] [Abstract][Full Text] [Related]
20. Why and how do microbubbles enhance the effectiveness of diagnostic and therapeutic interventions in cerebrovascular disease? Meairs S; Kern R; Alonso A Curr Pharm Des; 2012; 18(15):2223-35. PubMed ID: 22352776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]